Home
/
Day One Biopharmaceuticals, Inc.
/
Financials
/
Quarterly
Day One Biopharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Day One Biopharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$39.80M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$33.91M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$30.76M
May 6, 2025
Q3
2025
Sep 30, 2024
$93.76M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$8.19M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$0
May 6, 2025
Q3
2024
Sep 30, 2023
$0
Oct 30, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($19.73M)
Nov 4, 2025
Q3
2025
Jun 30, 2025
($30.32M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($30.32M)
Aug 5, 2025
Q2
2025
Mar 31, 2025
($36.00M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($36.00M)
May 6, 2025
Q3
2025
Mar 31, 2025
($36.00M)
Nov 4, 2025
Q3
2025
Sep 30, 2024
$37.04M
Nov 4, 2025
Q2
2025
Jun 30, 2024
($4.41M)
Aug 5, 2025
Q3
2025
Jun 30, 2024
($4.41M)
Nov 4, 2025
Q3
2025
Mar 31, 2024
($62.41M)
Nov 4, 2025
Q1
2025
Mar 31, 2024
($62.41M)
May 6, 2025
Q2
2025
Mar 31, 2024
($62.41M)
Aug 5, 2025
Q3
2024
Sep 30, 2023
($46.15M)
Oct 30, 2024
Q3
2024
Jun 30, 2023
($45.86M)
Oct 30, 2024
Q2
2024
Jun 30, 2023
($45.86M)
Aug 2, 2024
Q2
2024
Mar 31, 2023
($42.39M)
Aug 2, 2024
Q3
2024
Mar 31, 2023
($42.39M)
Oct 30, 2024
Q3
2022
Mar 31, 2021
($15.18M)
Nov 7, 2022
Q2
2022
Mar 31, 2021
($15.18M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($15.18M)
May 12, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($24.25M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($34.97M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($41.07M)
May 6, 2025
Q3
2025
Sep 30, 2024
$29.64M
Nov 4, 2025
Q2
2025
Jun 30, 2024
($114.81M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($66.77M)
May 6, 2025
Q3
2024
Sep 30, 2023
($51.44M)
Oct 30, 2024
Q2
2024
Jun 30, 2023
($49.25M)
Aug 2, 2024
Q1
2024
Mar 31, 2023
($45.86M)
May 6, 2024
Q3
2023
Sep 30, 2022
($39.70M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($36.72M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($27.75M)
May 1, 2023
Q3
2022
Sep 30, 2021
($19.24M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($15.44M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($16.09M)
May 12, 2022
Q3
2021
Sep 30, 2020
($3.56M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($2.31M)
Aug 10, 2021